Market Overview

J.P. Morgan Reiterates Underweight Rating, $34 PT on Paychex

Share:
Related PAYX
Mid-Afternoon Market Update: RH Gains After Strong Q4 Results; Quorum Health Shares Plummet
Mid-Day Market Update: Crude Oil Up 1.5%; Alliqua Biomedical Shares Slide

In a report published Wednesday, J.P. Morgan & Co. reiterated its Underweight rating and $34.00 price target on Paychex (NASDAQ: PAYX).

J.P. Morgan noted, “We are tweaking our PAYX estimates following a mixed F1Q with light revenues but few surprises. EPS of $0.42 compared to JPMe of $0.40 and Street of $0.41, with upside coming from cost efficiencies. Relevant payroll metrics were steady, with growth in checks per client continuing for the tenth consecutive quarter, retention near historic levels and modest increases in revenue per check. Management reiterated guidance, implying a pick up in revenue growth and a moderation in margins for the rest of the year. We reiterate our $34 price target and remain UW shares as we see limited EPS and multiple expansion near term.”

Paychex closed on Tuesday at $33.41.

Latest Ratings for PAYX

DateFirmActionFromTo
Jan 2017BernsteinUpgradesUnderperformMarket Perform
Dec 2016BarclaysInitiates Coverage OnEqual-Weight
Dec 2016Goldman SachsUpgradesNeutralBuy

View More Analyst Ratings for PAYX
View the Latest Analyst Ratings

Posted-In: J.P. Morgan & Co.Analyst Color Reiteration Analyst Ratings

 

Related Articles (PAYX)

View Comments and Join the Discussion!